Post-earnings recap
Reported
Wed, Feb 23, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's earnings report indicates a disappointing quarter, particularly with the EPS miss. The stock reacted negatively, dropping 3.34%, likely due to investor concerns over the company's current challenges and lack of guidance. Without clear direction for the future, investors may remain cautious.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.32 | N/A | -44.14% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed caution regarding the company's recent performance. They highlighted ongoing challenges but maintained a focus on future growth opportunities.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite current setbacks.